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142a Sunday, February 16, 2014been described. In KCNQ/Kv7 channels, the molecular determinants of the
M-current, a slow voltage-dependent non-inactivating neuronal potassium-
selective current, CaM binding is essential for channel trafficking to the
plasma membrane. The goal of the present work is to investigate whether
changes in the availability of CaM could influence membrane expression of
Kv7.2 channels. To this end, different ratios of Kv7.2 and CaM cDNAs
have been used to transfect HEK-293T cells, and the expressed current den-
sity has been assessed by whole-cell patch-clamp. When Kv7.2 and CaM
were transfected at a 1:1 cDNA ratio, Kv7.2 current density was identical
to that recorded in control cells. By contrast, increasing the CaM/Kv7.2
cDNA ratio to 10:1 and 20:1 caused a dose-dependent increase in current den-
sity (by 50 and 90%, respectively). Similar increases in current densities were
observed when Kv7.2 cDNA was transfected at identical ratios with a mutant
CaM unable to bind calcium (CaM1234). These results suggest that the
amount of apo-CaM accessible to Kv7.2 is limiting for channel function,
raising the intriguing possibility that changes in CaM availability meditated
by binding partners (eg. neurogranin, neuromodulin), which are known to
occur during long term potentation (Zhong et al., EMBO J, 28:3027, 2009),
might rely on changes in M-current density.
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M-currents, encoded by Kv7.2/7.3 genes, are low-threshold, voltage-gated
potassium channels which contribute to resting membrane potential (Vm)
and regulate neuronal excitability. Here, we tested the hypothesis that the
development of mouse striatal neurons is associated with enhanced expres-
sion and activity of M-currents and that determined whether forced expres-
sion of Kv7.2/7.3 accelerates the functional maturation of neurons
differentiating from human induced pluripotent stem (iPS) cells. Neurons
from the developing mouse striatum were isolated at E13, E15 and E17
and cultured in vitro for up to 14 days; functional profiles of the neurons
were explored using whole-cell patch-clamp. In some experiments, subven-
tricular and mantle zones were separated by laser microdissection and chan-
nel subunit ontogenies determined by gene chip array. Shortly after isolation
(1 day in vitro), there was a clear in vivo development-dependent hyperpo-
larisation of Vm (E13=-24.852.3 mV (n=26), E15=-40.052.2 mV (n=12),
E17=-47.252.4 mV (n=9)). Although Vm continued to hyperpolarise in
vitro, by 7 days these differences has disappeared (e.g. E13=-52.152.8
mV (n=8), E17 =-54.751.9 (n=5)). Associated with these observations,
were parallel and progressive increases in M-current activity during in
vivo and in vitro development, as evidenced by more pronounced responses
to retigabine and XE991. Further, both Kv7.2 and 7.3 genes were progres-
sively enriched in the mantle zone during in vivo development. Importantly,
human iPS cell-derived neurons nucleofected with a concatenated Kv7.2/7.3
cDNA plasmid demonstrated a significantly hyperpolarized Vm (from
39.952.2 mV (n=12) to 51.351.1 mV (n=11)) and a dramatic increase
in the proportion of cells generating action potentials spontaneously. Taken
together, these data indicate that development of striatal neurons is associ-
ated with increased M-current expression and that this might be causative
as suggested by the effect of forced Kv7.2/7.3 expression in the iPS cell-
derived neurons.
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KCNQ genes encode five Kv7 Kþ channel subunits (Kv7.1-Kv7.5). Four of
these (Kv7.2-Kv7.5) are expressed in the nervous system. Kv7.2 and Kv7.3are the principal molecular components of the slow voltage-gated M-chan-
nel, which regulates neuronal excitability. In this study, we demonstrate that
tamoxifen, an estrogen receptor antagonist used in the treatment of breast
cancer, inhibits Kv7.2/Kv7.3 currents heterologously expressed in human
embryonic kidney HEK-293 cells. Current inhibition by tamoxifen was
voltage independent but concentration-dependent. The IC50 for current in-
hibition was 1.68 5 0.44 mM. The voltage-dependent activation of the
channel was not modified. Tamoxifen inhibited Kv7.2 homomeric channels
with a higher potency (IC50 = 0.74 5 0.16 mM). The mutation Kv7.2
R463E increases phosphatidylinositol- 4,5-bisphosphate (PIP2) - channel
interaction and diminished dramatically the inhibitory effect of tamoxifen
compared with that for wild type Kv7.2. Conversely, the mutation Kv7.2
R463Q, which decreases PIP2 -channel interaction, increased tamoxifen po-
tency. Similar results were obtained on the heteromeric Kv7.2 R463Q/
Kv7.3 and Kv7.2 R463E/Kv7.3 channels, compared to Kv7.2/Kv7.3 WT.
Overexpression of type 2A PI(4)P5-kinase (PIP5K 2A) significantly
reduced tamoxifen inhibition of Kv7.2/Kv7.3 and Kv7.2 R463Q channels.
Our results suggest that tamoxifen inhibited Kv7.2/Kv7.3 channels by inter-
fering with PIP2-channel interaction because of its documented interaction
with PIP2 and the similar effect of tamoxifen on various PIP2 sensitive
channels.
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The IKs channel is a slowly activating potassium channel that generates one of
the potassium currents that limits the duration of the cardiac action potential.
The IKs channel consists of 4 pore forming alpha subunits (KCNQ1) and 2-4
beta subunits (KCNE1). The four KCNQ1 subunits form functional potassium
channels, but the KCNE1 beta subunit is necessary to recapitulate the slow
activation kinetics of the IKs channel. The mechanism by which KCNE1
slows the kinetics of KCNQ1 channels is a matter of current controversy.
Here, we use a combination of voltage clamp fluorometry (VCF) and gating
current measurements to show that IKs channel activation occurs in two steps:
(1) mutually independent voltage sensor movements in the four KCNQ1 sub-
units generate the main gating charge movement and underlie the delay in the
activation time course of the KCNQ1/KCNE1 currents, (2) a slower and
concerted conformational change of all four voltage sensors and the gate,
which opens the KCNQ1/KCNE1 channel. Gating currents develop with a
similar time and voltage dependence as the first fluorescence component, as
if the first component reports on the main S4 charge movement. In contrast
to other Kv channels, the voltage dependences of the main voltage sensor
movement and channel opening are separated by over 100 mV. The two acti-
vation steps in KCNQ1/KCNE1 channels can be farther separated by a
disease-causing mutation in KCNE1. We determine rates and voltage depen-
dence of the gating transitions to construct a model for KCNQ1/KCNE1 chan-
nels. Our model is consistent with that KCNQ1/KCNE1 channel has a fast S4
movement at negative voltages that moves the majority of gating charge and a
slower second conformational change at positive voltages that moves a
smaller amount of gating charge and opens the gate.
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The five KCNE b-subunits interact with several members of the Kv channels,
thereby modifying channel gating via the interaction of their single
transmembrane-spanning segment, the extracellular amino terminus, and/or
the intracellular carboxy terminus with the Kv a-subunit. Best studied is the
molecular basis of interactions between KCNE1 and Kv7.1, which, together,
supposedly form the native cardiac I(Ks) channel. Besides biophysical effects
the pharmacology of Kv7.1 is modulated by KCNE1. Kv7.1 is coexpressed
with different KCNEs in tissue specific combinations. Highly selective com-
ponds that can discriminate between Kv7.1/KCNEx-complexes may allow
for tissue specific action of drug candidates. Here, we present data on the first
highly potent, pure Kv7.1/KCNE1 inhibitor" that does not act on Kv7.1 alone.
We determine its binding site and interpret underlying structural mechanisms
of subtype selectivity.
